A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients with Metastatic Urothelial Cancer

R. Pili; R. Qin; P.J. Flynn; J. Picas; Michael Millward; W.M. Ho; H. Pitot; W. Tan; K.M. Miles; C. Erlichman; U. Vaishampayan

doi:10.1015/j.clgc.2013.05.005

A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients with Metastatic Urothelial Cancer

R. Pili
, R. Qin
, P.J. Flynn
, J. Picas
, Michael Millward
, W.M. Ho
, H. Pitot
, W. Tan
, K.M. Miles
, C. Erlichman
, U. Vaishampayan

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	477-88
Journal	Clinical Genitourinary Cancer
Volume	11
Issue number	4
DOIs	https://doi.org/10.1015/j.clgc.2013.05.005
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1015/j.clgc.2013.05.005

Cite this

Pili, R., Qin, R., Flynn, P. J., Picas, J., Millward, M., Ho, W. M., Pitot, H., Tan, W., Miles, K. M., Erlichman, C., & Vaishampayan, U. (2014). A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients with Metastatic Urothelial Cancer. Clinical Genitourinary Cancer, 11(4), 477-88. https://doi.org/10.1015/j.clgc.2013.05.005

@article{c02bd499c8c54f4b8b3e6312d5cf33b6,

title = "A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients with Metastatic Urothelial Cancer",

author = "R. Pili and R. Qin and P.J. Flynn and J. Picas and Michael Millward and W.M. Ho and H. Pitot and W. Tan and K.M. Miles and C. Erlichman and U. Vaishampayan",

year = "2014",

doi = "10.1015/j.clgc.2013.05.005",

language = "English",

volume = "11",

pages = "477--88",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier",

number = "4",

}

Pili, R, Qin, R, Flynn, PJ, Picas, J, Millward, M, Ho, WM, Pitot, H, Tan, W, Miles, KM, Erlichman, C & Vaishampayan, U 2014, 'A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients with Metastatic Urothelial Cancer', Clinical Genitourinary Cancer, vol. 11, no. 4, pp. 477-88. https://doi.org/10.1015/j.clgc.2013.05.005

TY - JOUR

T1 - A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients with Metastatic Urothelial Cancer

AU - Pili, R.

AU - Qin, R.

AU - Flynn, P.J.

AU - Picas, J.

AU - Millward, Michael

AU - Ho, W.M.

AU - Pitot, H.

AU - Tan, W.

AU - Miles, K.M.

AU - Erlichman, C.

AU - Vaishampayan, U.

PY - 2014

Y1 - 2014

U2 - 10.1015/j.clgc.2013.05.005

DO - 10.1015/j.clgc.2013.05.005

M3 - Article

SN - 1558-7673

VL - 11

SP - 477

EP - 488

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

IS - 4

ER -